ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2256

Improved Outcomes of Acute Myocardial Infarction Among Patients with Rheumatoid Arthritis: A Propensity Matched National Study

Qurat Ul Ain1 and MIrza faris Ali Baig2, 1Medstar Georgetown University Hospital, Arlington, VA, 2Medstar Health, Arlington, VA

Meeting: ACR Convergence 2025

Keywords: Cardiovascular, Myocardial Infarction, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2227–2264) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The increased risk of cardiovascular morbidity and mortality with rheumatoid arthritis has been increasingly acknowledged over the past decades. Cardiovascular disease risk management for patients with rheumatoid arthritis is essential. This retrospective population-based study investigated in-hospital outcomes among adult patients admitted with acute myocardial infarction (AMI), with a specific focus on the impact of rheumatoid arthritis (RA) on these outcomes.

Methods: Data was derived from the National Inpatient Sample (NIS) database, between January 1, 2018 and December 31, 2021,encompassing a large and diverse cohort of hospitalized individuals. The primary outcome analyzed was in-hospital mortality, with secondary outcomes being the utilization of diagnostic angiography, rates of percutaneous coronary intervention (PCI), and the incidence of complications such as acute kidney injury (AKI), cardiogenic shock, cardiac arrest, ventricular tachycardia (VT), ventricular fibrillation (VF), as well as requirements for mechanical ventilation, tracheal intubation, and mechanical circulatory support (MCS). Additional parameters examined were length of stay (LOS) and total hospitalization charges. The study population comprised of 2,275,150 patients, predominantly Caucasian (71%), followed by African American patients (11%), with females representing 36.4% of the cohort. The mean age across the population was 66.5 years (±2.8 years). Among these patients, 39,270 (1.7%) had a documented history of rheumatoid arthritis. Owing to the significant difference in sample size between patients with AMI in the presence and absence of RA, a propensity score matching (PSM) algorithm was employed to generate comparable groups. Post-matching, 15,703 patients from each cohort were selected, ensuring a similar distribution of age, sex, race, and Charlson Comorbidity Index score.

Results: Comparative analysis of the matched cohorts revealed notable differences in outcomes. Patients with RA experienced a lower rate of in-hospital mortality (3.8% vs. 4.8%, P < 0.001) compared to those without RA. Additionally, the utilization of mechanical circulatory support was lower in the RA group (2.9% vs. 4.2%). In contrast, the RA cohort demonstrated higher rates of diagnostic angiography (74% vs. 71%, P < 0.001) and PCI (48% vs. 44%), suggesting a more aggressive diagnostic and interventional approach.

Conclusion: The study highlights that despite previous associations of rheumatoid arthritis with increased mortality largely due to cardiovascular complications, advancements in disease management and therapeutic interventions may have contributed to improved in-hospital outcomes in this subgroup. The observed higher utilization of diagnostic and interventional procedures in the RA group may reflect heightened clinical vigilance and a lower threshold for invasive testing in this high-risk population. Overall, these findings underscore the importance of continued physicain and pateint education, along with implementation of preventive strategies, to optimize outcomes in patients with Rheumatoid arthritis.

Supporting image 1Figure 1.0 Schema representing study population pre and post propensity score matching.

Supporting image 2Figure-2 Post propensity pateint characteristics

Supporting image 3Figure-3 Outlines lower rate of Acute myocardial infarction (AMI) moratality, lower utilization of mechanical circulatory support, higher rates of diagnostic angiography and PCI in RA group.


Disclosures: Q. Ul Ain: None; M. Baig: None.

To cite this abstract in AMA style:

Ul Ain Q, Baig M. Improved Outcomes of Acute Myocardial Infarction Among Patients with Rheumatoid Arthritis: A Propensity Matched National Study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/improved-outcomes-of-acute-myocardial-infarction-among-patients-with-rheumatoid-arthritis-a-propensity-matched-national-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improved-outcomes-of-acute-myocardial-infarction-among-patients-with-rheumatoid-arthritis-a-propensity-matched-national-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology